<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26-vaccines-08-00306">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jeong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>G.B.</given-names>
   </name>
   <name>
    <surname>Ji</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kwak</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Nam</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>An</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dendritic cell activation by an e. Coli-derived monophosphoryl lipid a enhances the efficacy of pd-1 blockade</article-title>
  <source>Cancer Lett.</source>
  <year>2020</year>
  <volume>472</volume>
  <fpage>19</fpage>
  <lpage>28</lpage>
  <pub-id pub-id-type="doi">10.1016/j.canlet.2019.12.012</pub-id>
  <pub-id pub-id-type="pmid">31857157</pub-id>
 </element-citation>
</ref>
